在老鼠中,多巴胺过敏与反向努力-成本依赖性表现相关
Artem Savchenko1,2, Irina Belozertseva2, Damiana Leo3
1Programme for Proteomics, Paracelsus Medical University, Salzburg, Austria.
Journal of psychopharmacology (Oxford, England)
|November 14, 2023
概括
在缺乏多巴胺转运体 (DAT) 的老鼠中,突触多巴胺水平升高显著增加了动机和努力-成本参与度. 这表明增强剂多巴胺在调节动机过程中起着至关重要的作用.
科学领域:
- 神经科学是一个神经科学.
- 行为神经科学 行为神经科学
- 分子生物学分子生物学
背景情况:
- 多巴胺对基于努力的动机至关重要.
- 增强剂多巴胺在调节努力成本对动机的影响中的确切作用仍在争论中.
研究的目的:
- 研究突触多巴胺在激励过程中的作用.
- 阐明提升的增强性多巴胺如何影响动机-努力成本关系.
主要方法:
- 利用基因工程使得缺乏多巴胺载体 (DAT-KO) 的老鼠,从而增加了突触性多巴胺.
- 采用渐进式比率3 (PR3) 操作时间表与食物强化来评估奖励相关的过程.
- 与DAT-KO,异合体 (DAT-HT) 和野生类型 (DAT-WT) 的大鼠进行比较.
主要成果:
- 随着所需反应的增加,DAT-KO大鼠的响应率增加,而不是DAT-WT和DAT-HT大鼠的响应率下降.
- D-安非他胺的使用使大鼠的DAT-WT反应率正常化,使其与DAT-KO大鼠相似.
- 用安非他胺治疗的DAT-WT大鼠的应答率降低与杂志条目减少相关,但在DAT-KO大鼠中没有.
结论:
- 增强的突触性多巴胺显著影响动物的动机-努力成本关系.
- 这些发现强调了突触多巴胺在调节基于努力的决策中的关键作用.
更多相关视频
07:42An Automated T-maze Based Apparatus and Protocol for Analyzing Delay- and Effort-based Decision Making in Free Moving Rodents
Published on: August 2, 2018
13.7K
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
2.8K
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
